LillyDirect (Eli Lilly) vs MEDVi: Which Is Cheaper? GLP-1 Prices Compared
Last updated
Each seller's lowest price now
The same medicine for less than LillyDirect (Eli Lilly) and MEDVi, at sellers we link to
They pay us if you buy, which never changes a price we show.
LillyDirect (Eli Lilly) and MEDVi have no listed product in common here: LillyDirect (Eli Lilly) lists Foundayo pill (from $149/mo), Zepbound injection ($299-$449/28 days), Trulicity injection (from $389/28 days), and Mounjaro injection (from $499/28 days); MEDVi lists compounded semaglutide injection ($199/mo) and compounded tirzepatide injection ($299/mo). Both sell tirzepatide, as different products: Zepbound injection and Mounjaro injection at LillyDirect (Eli Lilly), compounded tirzepatide injection at MEDVi. What each lists a price for here: LillyDirect (Eli Lilly), FDA-approved brand-name GLP-1s only; MEDVi, compounded GLP-1s only. Compounded GLP-1s are not FDA-approved. Prices checked Nov 11, 2026 and Nov 13, 2026.
Every cash quote was checked on or after . Each quote shows its own check date. A quoted price is not a recommendation of a seller, a product or a dose. How we source prices
What LillyDirect (Eli Lilly) and MEDVi each list
Both sell tirzepatide, as different products: Zepbound injection and Mounjaro injection at LillyDirect (Eli Lilly), compounded tirzepatide injection at MEDVi.
Foundayo pill
Advertised entry price
from $149/mo (lilly.com/lillydirect/foundayo)30-day supply (lilly.com)
$149 per 30 days at this quoted rate
Checked on lilly.com
Foundayo (LillyDirect self-pay)
LillyDirect (Eli Lilly) · maker's own priceself-pay cash, lowest dose; as low as $25 a month for eligible patients with commercial coverage for Foundayo ("you could pay as low as $25 a month")
Price conditions
self-pay cash, lowest dose; as low as $25 a month for eligible patients with commercial coverage for Foundayo ("you could pay as low as $25 a month")
LillyDirect self-pay ladder, each a 30-day supply: $149 (0.8 mg), $199 (2.5 mg), $299 (5.5 and 9 mg), $299 (14.5 and 17.2 mg with a 45-day refill, else $349); the 2.5 mg and 5.5 mg doses are temporarily $149 and $199 through Dec 31, 2026.
30-day supply
Published maintenance dose
$299/mo (lilly.com/lillydirect/foundayo/foundayo-full-terms-conditions)30-day supply (lilly.com)
$299 per 30 days at this quoted rate
Checked on lilly.com
At 17.2 mg
Foundayo (LillyDirect self-pay)
LillyDirect (Eli Lilly) · maker's own pricePublished price at 17.2 mg
Price conditions
Published price at 17.2 mg
LillyDirect self-pay ladder, each a 30-day supply: $149 (0.8 mg), $199 (2.5 mg), $299 (5.5 and 9 mg), $299 (14.5 and 17.2 mg with a 45-day refill, else $349); the 2.5 mg and 5.5 mg doses are temporarily $149 and $199 through Dec 31, 2026.
Self-Pay Journey price for 14.5 mg and 17.2 mg with a refill within 45 days; regular price $349. Eligibility, additional taxes and fees may apply.
30-day supply
Zepbound injection
Advertised entry price
$299-$449/28 days (zepbound.lilly.com/hcp/coverage-savings)28-day supply (zepbound.lilly.com)
≈ $320.36 per 30 days at this quoted rate
Checked on zepbound.lilly.com
Zepbound KwikPen (multi-dose pen)
LillyDirect (Eli Lilly) · maker's own priceself-pay cash, by dose ($299 / $399 / $449)
Price conditions
self-pay cash, by dose ($299 / $399 / $449)
Each pen holds four doses, one month's (28-day) supply. $299 at 2.5 mg and $399 at 5 mg; $449 at 7.5 to 15 mg under the Self Pay Journey offer, which holds only with a refill within 45 days.
28-day supply
Published maintenance dose
$449/28 days (zepbound.lilly.com/hcp/coverage-savings)28-day supply (zepbound.lilly.com)
≈ $481.07 per 30 days at this quoted rate
Checked on zepbound.lilly.com
At 15 mg
Zepbound KwikPen (multi-dose pen)
LillyDirect (Eli Lilly) · maker's own pricePublished price at 15 mg
Price conditions
Published price at 15 mg
Each pen holds four doses, one month's (28-day) supply. $299 at 2.5 mg and $399 at 5 mg; $449 at 7.5 to 15 mg under the Self Pay Journey offer, which holds only with a refill within 45 days.
Self Pay Journey price for 7.5-15 mg with a refill within 45 days; otherwise $499 (7.5 mg) or $699 (10-15 mg).
28-day supply
Trulicity injection
Advertised entry price
from $389/28 days (lilly.com/lillydirect/trulicity)28-day supply (lilly.com)
≈ $416.79 per 30 days at this quoted rate
Checked on lilly.com
Trulicity single-dose pens
LillyDirect (Eli Lilly) · maker's own priceself-pay, four weekly pens; published starting rate at each dose
Price conditions
self-pay, four weekly pens; published starting rate at each dose
The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.
28-day supply
Published maintenance dose
from $389/28 days (lilly.com/lillydirect/trulicity)28-day supply (lilly.com)
≈ $416.79 per 30 days at this quoted rate
Checked on lilly.com
At 4.5 mg
Trulicity single-dose pens
LillyDirect (Eli Lilly) · maker's own pricePublished price at 4.5 mg
Price conditions
Published price at 4.5 mg
The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.
The same starting rate is published for 0.75, 1.5, 3 and 4.5 mg. Taxes and additional fees may apply.
28-day supply
Mounjaro injection
Advertised entry price
from $499/28 days (lilly.com/lillydirect/mounjaro)28-day supply (lilly.com)
≈ $534.64 per 30 days at this quoted rate
Checked on lilly.com
Mounjaro single-dose pens
LillyDirect (Eli Lilly) · maker's own priceself-pay, four weekly pens; published starting rate at each dose
Price conditions
self-pay, four weekly pens; published starting rate at each dose
The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.
28-day supply
Published maintenance dose
from $499/28 days (lilly.com/lillydirect/mounjaro)28-day supply (lilly.com)
≈ $534.64 per 30 days at this quoted rate
Checked on lilly.com
At 15 mg
Mounjaro single-dose pens
LillyDirect (Eli Lilly) · maker's own pricePublished price at 15 mg
Price conditions
Published price at 15 mg
The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.
The same starting rate is published for all six strengths, 2.5-15 mg. Taxes and additional fees may apply.
28-day supply
Compounded semaglutide injection
Advertised entry price
$199/mo (glp1.medvi.org)Billed per month; days of supply not on record, so ordered as four weekly doses.
Checked on glp1.medvi.org
Compounded semaglutide via MEDVi
MEDVi · seller's own pricerefill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract
Price conditions
refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract
Weekly injection. Another MEDVi landing page shows semaglutide at $116 a month in one place and $166 a month in its FAQ. MEDVi also sells a daily GLP-1 tablet from $249 without naming the drug. Compounded; not FDA-approved.
Compounded tirzepatide injection
Advertised entry price
$299/mo (glp1.medvi.org/results/cv-tirz)28-day supply (glp1.medvi.org)
≈ $320.36 per 30 days at this quoted rate
Checked on glp1.medvi.org
Compounded tirzepatide via MEDVi
MEDVi · seller's own pricemonthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)
Price conditions
monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)
Weekly injection. Another MEDVi landing page shows tirzepatide at $166 a month, and $199 a month in its FAQ. Multi-month packages are not refunded for unused months. Compounded; not FDA-approved.
28-day supply
Published maintenance dose
$299/mo (glp1.medvi.org/results/cv-tirz)28-day supply (glp1.medvi.org)
≈ $320.36 per 30 days at this quoted rate
Checked on glp1.medvi.org
At 15 mg
Compounded tirzepatide via MEDVi
MEDVi · seller's own pricemonthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)
Price conditions
monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)
Weekly injection. Another MEDVi landing page shows tirzepatide at $166 a month, and $199 a month in its FAQ. Multi-month packages are not refunded for unused months. Compounded; not FDA-approved.
The seller states one price at every dose, so this is also its price at 15 mg.
28-day supply
Cheaper than LillyDirect (Eli Lilly) and MEDVi
Other sellers' current prices for the same product, below the lower of these two, compared per 30 days where both state their supply. Compounded medication is compared only with compounded, and an FDA-approved product only with itself.
Compounded, not FDA-approved
Compounded semaglutide
Lower than MEDVi. MEDVi: $199/mo, checked Nov 11, 2026 on glp1.medvi.org.
- Collective: $59/mo + $199/yr membership. Checked Nov 15, 2026 on collective.org.View offer
- Sunlight: $78/mo, about $84 per 30 days. Checked Nov 11, 2026 on sunlight.com.View offer
- Avono Health: $79/mo. Checked Nov 13, 2026 on avonohealth.com.View offer
- Embody: $79/mo. Checked Nov 14, 2026 on joinem.co.View offer
Compounded, not FDA-approved
Compounded tirzepatide
Lower than MEDVi. MEDVi: $299/mo, checked Nov 13, 2026 on glp1.medvi.org.
- Collective: $69/mo + $199/yr membership. Checked Nov 15, 2026 on collective.org.View offer
- FlatRx: $118/mo. Checked Nov 17, 2026 on flatrx.io.View offer
- Arbor: $119/mo. Checked Nov 13, 2026 on startarbor.com.View offer
- Mint Med: $119/mo. Checked Nov 11, 2026 on mintmed.com.View offer
Compounded GLP-1s are not FDA-approved. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. FDA: concerns with unapproved GLP-1 drugs used for weight loss (fda.gov)
LillyDirect (Eli Lilly) vs MEDVi: common questions
Is LillyDirect (Eli Lilly) or MEDVi cheaper for GLP-1 medication?
They have no listed product in common here, so neither is shown as cheaper for the same medication. Only LillyDirect (Eli Lilly): Foundayo pill from $149/mo; Zepbound injection $299-$449/28 days; Trulicity injection from $389/28 days; Mounjaro injection from $499/28 days. Only MEDVi: Compounded semaglutide injection $199/mo; Compounded tirzepatide injection $299/mo. Both sell tirzepatide, as different products: Zepbound injection and Mounjaro injection at LillyDirect (Eli Lilly), compounded tirzepatide injection at MEDVi. A compounded product is not a cheaper version of an FDA-approved brand; it is a different, unapproved product.
Do LillyDirect (Eli Lilly) and MEDVi sell FDA-approved GLP-1s or compounded versions?
What each lists a price for here: LillyDirect (Eli Lilly), FDA-approved brand-name GLP-1s only; MEDVi, compounded GLP-1s only. Compounded GLP-1s are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality.
What do LillyDirect (Eli Lilly) and MEDVi prices include?
LillyDirect (Eli Lilly), Foundayo pill: from $149/mo, self-pay cash, lowest dose; as low as $25 a month for eligible patients with commercial coverage for Foundayo ("you could pay as low as $25 a month"). LillyDirect (Eli Lilly), Zepbound injection: $299-$449/28 days, self-pay cash, by dose ($299 / $399 / $449). LillyDirect (Eli Lilly), Trulicity injection: from $389/28 days, self-pay, four weekly pens; published starting rate at each dose. LillyDirect (Eli Lilly), Mounjaro injection: from $499/28 days, self-pay, four weekly pens; published starting rate at each dose. MEDVi, compounded semaglutide injection: $199/mo, refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract. MEDVi, compounded tirzepatide injection: $299/mo, monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months).
When were LillyDirect (Eli Lilly) and MEDVi prices last checked?
Prices checked Nov 11, 2026 and Nov 13, 2026. Each quote names the seller's own page it was read from. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.
All LillyDirect (Eli Lilly) and MEDVi offers
Both sellers' quotes in one table, lowest 30-day cost first where the seller states its supply.
Search by medication, seller or treatment goal, for example: cheapest Wegovy pill.
9 current prices
Lowest starting 30-day cost · US self-pay in
- View offer
Foundayo (LillyDirect self-pay)LillyDirect (Eli Lilly)· Manufacturer direct
from $149/mo (lilly.com/lillydirect/foundayo)Checked on lilly.com
Top dose:$299/mo (lilly.com/lillydirect/foundayo/foundayo-full-terms-conditions)at 17.2 mg
Checked on lilly.com
Terms & source
Advertised price: self-pay cash, lowest dose; as low as $25 a month for eligible patients with commercial coverage for Foundayo ("you could pay as low as $25 a month")
30-day supply (lilly.com)
$149 per 30 days at this quoted rate
Top-dose terms: Self-Pay Journey price for 14.5 mg and 17.2 mg with a refill within 45 days; regular price $349. Eligibility, additional taxes and fees may apply.
LillyDirect self-pay ladder, each a 30-day supply: $149 (0.8 mg), $199 (2.5 mg), $299 (5.5 and 9 mg), $299 (14.5 and 17.2 mg with a 45-day refill, else $349); the 2.5 mg and 5.5 mg doses are temporarily $149 and $199 through Dec 31, 2026.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.
Advertised price as read on its own page (lilly.com) Terms & source
Advertised price: refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract
Billed per month; days of supply not on record, so ordered as four weekly doses.
Weekly injection. Another MEDVi landing page shows semaglutide at $116 a month in one place and $166 a month in its FAQ. MEDVi also sells a daily GLP-1 tablet from $249 without naming the drug. Compounded; not FDA-approved.
Partner: This seller may pay us a referral fee if you buy through our link, at no extra cost to you. That moves it up in our default order, never in a lowest-cost sort, and is not a medical recommendation.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.
Advertised price as read on its own page (glp1.medvi.org)- View offer
Zepbound KwikPen (multi-dose pen)LillyDirect (Eli Lilly)· Manufacturer direct
$299-$449/28 days (zepbound.lilly.com/hcp/coverage-savings)≈ $320.36 per 30 days
Checked on zepbound.lilly.com
Top dose:$449/28 days (zepbound.lilly.com/hcp/coverage-savings)at 15 mg
≈ $481.07 per 30 days
Checked on zepbound.lilly.com
Terms & source
Advertised price: self-pay cash, by dose ($299 / $399 / $449)
28-day supply (zepbound.lilly.com)
≈ $320.36 per 30 days at this quoted rate
Top-dose terms: Self Pay Journey price for 7.5-15 mg with a refill within 45 days; otherwise $499 (7.5 mg) or $699 (10-15 mg).
Each pen holds four doses, one month's (28-day) supply. $299 at 2.5 mg and $399 at 5 mg; $449 at 7.5 to 15 mg under the Self Pay Journey offer, which holds only with a refill within 45 days.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.
Advertised price as read on its own page (zepbound.lilly.com) - View offer
Zepbound single-dose vials (2.5 mg)LillyDirect (Eli Lilly)· Manufacturer direct
$299/28 days (zepbound.lilly.com/hcp/coverage-savings)≈ $320.36 per 30 days
Checked on zepbound.lilly.com
Top dose:$449/28 days (zepbound.lilly.com/hcp/coverage-savings)at 15 mg
≈ $481.07 per 30 days
Checked on zepbound.lilly.com
Terms & source
Advertised price: self-pay cash, starting dose
28-day supply (zepbound.lilly.com)
≈ $320.36 per 30 days at this quoted rate
Top-dose terms: Self Pay Journey price for 7.5-15 mg with a refill within 45 days; otherwise $499 (7.5 mg) or $699 (10-15 mg).
Self-pay only, available exclusively through LillyDirect Pharmacy. Lilly states that 2.5 mg starts treatment and is not a maintenance dose.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.
Advertised price as read on its own page (zepbound.lilly.com) - View offer
$299/mo (glp1.medvi.org/results/cv-tirz)≈ $320.36 per 30 days
Checked on glp1.medvi.org
Top dose: same priceSame price at 15 mg
Terms & source
Advertised price: monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)
28-day supply (glp1.medvi.org)
≈ $320.36 per 30 days at this quoted rate
Other plan lengths
- $193/mo on 3 months
- $183/mo on 6 months
- $166/mo on 12 months
Top-dose terms: The seller states one price at every dose, so this is also its price at 15 mg.
Weekly injection. Another MEDVi landing page shows tirzepatide at $166 a month, and $199 a month in its FAQ. Multi-month packages are not refunded for unused months. Compounded; not FDA-approved.
Partner: This seller may pay us a referral fee if you buy through our link, at no extra cost to you. That moves it up in our default order, never in a lowest-cost sort, and is not a medical recommendation.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.
Advertised price as read on its own page (glp1.medvi.org) - View offer
Trulicity single-dose pensLillyDirect (Eli Lilly)· Manufacturer direct
from $389/28 days (lilly.com/lillydirect/trulicity)≈ $416.79 per 30 days
Checked on lilly.com
Top dose: same priceSame price at 4.5 mg
Terms & source
Advertised price: self-pay, four weekly pens; published starting rate at each dose
28-day supply (lilly.com)
≈ $416.79 per 30 days at this quoted rate
Top-dose terms: The same starting rate is published for 0.75, 1.5, 3 and 4.5 mg. Taxes and additional fees may apply.
The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.
Advertised price as read on its own page (lilly.com) - View offer
Zepbound single-dose vials (5 mg)LillyDirect (Eli Lilly)· Manufacturer direct
$399/28 days (zepbound.lilly.com/hcp/coverage-savings)≈ $427.50 per 30 days
Checked on zepbound.lilly.com
Top dose:$449/28 days (zepbound.lilly.com/hcp/coverage-savings)at 15 mg
≈ $481.07 per 30 days
Checked on zepbound.lilly.com
Terms & source
Advertised price: self-pay cash
28-day supply (zepbound.lilly.com)
≈ $427.50 per 30 days at this quoted rate
Top-dose terms: Self Pay Journey price for 7.5-15 mg with a refill within 45 days; otherwise $499 (7.5 mg) or $699 (10-15 mg).
Self-pay only, available exclusively through LillyDirect Pharmacy.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.
Advertised price as read on its own page (zepbound.lilly.com) - View offer
Zepbound single-dose vials (7.5-15 mg)LillyDirect (Eli Lilly)· Manufacturer direct
$449/28 days (zepbound.lilly.com/hcp/coverage-savings)≈ $481.07 per 30 days
Checked on zepbound.lilly.com
Top dose: same priceSame price at 15 mg
Terms & source
Advertised price: self-pay cash, higher doses
28-day supply (zepbound.lilly.com)
≈ $481.07 per 30 days at this quoted rate
Top-dose terms: Self Pay Journey price for 7.5-15 mg with a refill within 45 days; otherwise $499 (7.5 mg) or $699 (10-15 mg).
The $449 rate is the Self Pay Journey Program price and holds only with a refill within 45 days; miss the window and the higher doses revert to the regular single-dose vial price of $499 (7.5 mg) or $699 (10 mg, 12.5 mg, and 15 mg).
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.
Advertised price as read on its own page (zepbound.lilly.com) - View offer
Mounjaro single-dose pensLillyDirect (Eli Lilly)· Manufacturer direct
from $499/28 days (lilly.com/lillydirect/mounjaro)≈ $534.64 per 30 days
Checked on lilly.com
Top dose: same priceSame price at 15 mg
Terms & source
Advertised price: self-pay, four weekly pens; published starting rate at each dose
28-day supply (lilly.com)
≈ $534.64 per 30 days at this quoted rate
Top-dose terms: The same starting rate is published for all six strengths, 2.5-15 mg. Taxes and additional fees may apply.
The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.
Advertised price as read on its own page (lilly.com)
Read prices in context. Compare the same product, dose and payment terms; missing prices are not estimated. Compounded medicines are not FDA-approved.
How this list is ordered. Some sellers may pay us a referral fee, as their terms say. In this sort they are not moved up, and it never changes what you pay.
How prices are compared, what FDA says about compounding and how we earn
A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes, converted to 30 days: by the supply a price buys where the seller states it in days, otherwise a monthly price with its plan length on record read as four weekly doses, a yearly membership in the price spread over twelve months. Introductory prices, ranges, prices with no plan length on record and separately billed fees are unranked references. Dose changes and added fees affect what you pay.
A listed maintenance dose is not a dosing recommendation.
FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved (fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize). Its conditions for a pharmacy compounding them now include "The drug product is compounded for an individual patient based on receipt of a prescription" and "The compounder does not compound, regularly or in inordinate amounts, any that are essentially copies of a commercially available drug product." (fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize) In May 2026 FDA proposed leaving semaglutide, tirzepatide and liraglutide off the 503B Bulks List (federalregister.gov/documents/2026/05/01/2026-08552/list-of-bulk-drug-substances-for-which-there-is-a-clinical-need-under-section-503b-of-the-federal), the ingredients outsourcing facilities may compound from; comments closed Jul 30, 2026 (govinfo.gov/content/pkg/FR-2026-06-26/html/2026-12937.htm), and we found no final notice when we last read the Federal Register (Nov 6, 2026). FDA's newest warning letter to a pharmacy over compounded semaglutide or tirzepatide went to Empower Clinic Services, LLC dba Empower Pharmacy (fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/empower-clinic-services-llc-dba-empower-pharmacy-738238-09182026) on Sep 18, 2026 (every GLP-1 warning letter). FDA's newest recall report of a compounded semaglutide or tirzepatide product is Houston Rx LLC's tirzepatide (api.fda.gov/drug/enforcement.json), reported Oct 21, 2026: "Lack of assurance of sterility." (every tirzepatide recall). Liraglutide is different: FDA's shortage database (accessdata.fda.gov/scripts/drugshortages) still lists it in shortage (updated at source Oct 14, 2026; every GLP-1 shortage). FDA: "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed." (fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers) A low price is not a low-risk signal; confirm current terms with the provider.
GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.
GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.
LillyDirect (Eli Lilly) vs MEDVi: reviews, BBB and FDA
What Trustpilot, the BBB and the FDA say about each. These records do not measure medical quality or results.
MEDVi
Trustpilot 4.3 from 15,227 reviews. The BBB rates MEDVi F, with 789 complaints filed in the last 3 years. It is not BBB accredited. The FDA sent MEDVi a warning letter (Feb 20, 2026) about claims on its website. The words that letter quotes ("Same active ingredient as Wegovy® and Ozempic®") were on none of the 3 pages of home.medvi.org and glp1.medvi.org we read on Nov 16, 2026.
Is MEDVi legit?Seller pages re-read automatically : 2 of 6 opened and checked for price changes. How prices stay current
LillyDirect (Eli Lilly) and MEDVi price changes
- Seller recordMEDVi: updated record on its public ratings and records
- PriceMEDVi: Compounded tirzepatide via MEDVi now ranked per 30 days at about $320: $299/mo buys 28 days (read on glp1.medvi.org)
- Seller recordMEDVi: updated record on who makes its medicine (read on home.medvi.org)
- PriceMEDVi: Compounded semaglutide via MEDVi now $199/mo (was $299/mo) (read on glp1.medvi.org)
Written from each source's own record as it changes. Every change on GLPcompare